120 related articles for article (PubMed ID: 8895162)
1. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury.
Matucci-Cerinic M; Jaffa A; Kahaleh B
J Lab Clin Med; 1992 Sep; 120(3):428-33. PubMed ID: 1325530
[TBL] [Abstract][Full Text] [Related]
3. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
4. [Decreased circulating endothelial progenitor cell function: relationship with serum concentrations of high-sensitivity C-reactive protein in children with Kawasaki disease].
Xu MG; Men LN; Wang HX; Zu Y; Zhao CY; Zhao X; Cai HB; Meng XC; Wang T
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):513-7. PubMed ID: 20637144
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
6. [Serum level of angiotensin-converting enzyme in sarcoidosis. Attempted correlation with the clinical activity of the disease (author's transl)].
Larzul JJ; Le Treut A; Couliou H; Beaumont D; Delaval P; Sapene M; de Labarthe B
Nouv Presse Med; 1981 Feb; 10(9):675-8. PubMed ID: 6259614
[TBL] [Abstract][Full Text] [Related]
7. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
8. Circulating adiponectin levels in Kawasaki disease.
Takeshita S; Takabayashi H; Yoshida N
Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Inoue N; Takai S; Jin D; Okumura K; Okamura N; Kajiura M; Yoshikawa S; Kawamura N; Tamai H; Miyazaki M
Clin Chim Acta; 2010 Feb; 411(3-4):267-9. PubMed ID: 19945447
[TBL] [Abstract][Full Text] [Related]
11. Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?
Falcini F; Generini S; Pignone A; Leoncini G; Cimaz R; Partsch G; Matucci-Cerinic M
Endothelium; 1999; 6(3):209-15. PubMed ID: 10365772
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of recurrent Kawasaki disease in 20 children].
Zou LX; Gong FQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
[TBL] [Abstract][Full Text] [Related]
13. [Circulating interleukin-4 levels in acute phase Kawasaki disease].
Hirao J; Hibi S; Andoh T; Ichimura T
Arerugi; 1996 Oct; 45(10):1137-9. PubMed ID: 8958662
[TBL] [Abstract][Full Text] [Related]
14. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
Maury CP; Salo E; Pelkonen P
J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
[TBL] [Abstract][Full Text] [Related]
17. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
[TBL] [Abstract][Full Text] [Related]
18. Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism.
Huang HP; Lai YC; Tsai IJ; Chen SY; Cheng CH; Tsau YK
Pediatr Res; 2008 Feb; 63(2):207-10. PubMed ID: 18091351
[TBL] [Abstract][Full Text] [Related]
19. Hair loss as a sign of Kawasaki disease.
Nabavizadeh SH; Safari M; Amin R
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
